Aug 6, 2009
Most Claims Dismissed in Wellbutrin Case
A federal judge has dealt a major setback to the “indirect purchaser” plaintiffs in the massive antitrust litigation over the marketing of Wellbutrin XL, a popular antidepressant drug, by tossing out most of the claims on standing grounds. The plaintiffs, a group of employee benefit plans, were aiming to pursue the case as a class action, but U.S.